Franklin Resources’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
Other funds holding TVTX
AC
PA
VCM
NAMI
Franklin Resources's TVTX Position: Q1 2026 in Review
Franklin Resources increased its Travere Therapeutics (TVTX) stake by 33% in Q1 2026, buying an estimated $911K and bringing the position to 124,192 shares worth $3.69M. The position accounts for ﹤0.01% of the portfolio, ranked #1661.
Franklin Resources first reported a position in TVTX in Q1 2015 and has held it in 19 quarters since. The position peaked at $48.7M in Q2 2015. 260 funds tracked by Wall St. Rank hold TVTX as of Q1 2026.
- Franklin Resources held 124,192 shares of Travere Therapeutics worth $3.69M as of Q1 2026.
- Franklin Resources bought 30,490 Travere Therapeutics shares in Q1 2026, an estimated $911K.
- Travere Therapeutics made up ﹤0.01% of Franklin Resources's portfolio in Q1 2026, its #1661 holding.
- Franklin Resources first reported a position in Travere Therapeutics in Q1 2015 and has held it in 19 quarters since.
- Franklin Resources's Travere Therapeutics position peaked at $48.7M in Q2 2015.
- 260 funds tracked by Wall St. Rank held Travere Therapeutics as of Q1 2026.
Based on Franklin Resources's 13F filing for Q1 2026, filed 13 May 2026.